MedPath

Endometrial Volume as a Predictor of Endometrial Pathology in Perimenopausal Uterine Bleeding Endometrial Volume as a Predictor of Endometrial Pathology in Perimenopausal Uterine Bleeding

Not Applicable
Conditions
Endometrial Disorder
Registration Number
NCT03351673
Lead Sponsor
Mansoura University
Brief Summary

Endometrial thickness has been used as an indicator of risk for endometrial hyperplasia and carcinoma in asymptomatic perimenopausal women. However, there is no cutoff value in perimenopausal women and the same thickness does not express the same endometrial volume in different endometrium because uterine lengths may be different and endometrial irregularities may exist. Many studies assessed endometrial volume measured by three-dimensional (3D) TVS as a predictor of malignancy in women with postmenopausal bleeding. To our knowledge there is no study assess endometrial volume measured by two dimension TVS in prediction of endometrial pathology, however it is cheap and available than 3D TVS.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
100
Inclusion Criteria

*perimenopausal women with abnormal bleeding e.g. menorrhagia, metrorrhagia and polymenorrhea.

Exclusion Criteria

*general or local causes of bleeding, drug intake or recent hormonal contraception

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
accuracy of measurement of endometrial volume by 2D TVS in prediction of endometrial pathology1year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

mansoura University

🇪🇬

Mansourah, Dakahlia, Egypt

mansoura University
🇪🇬Mansourah, Dakahlia, Egypt
hanan nabil, MD
Contact
00201000571004
hanannobil00@yahoo.com
waleed Elrefaie, MD
Contact
00201224515318
wrefaie@yahoo.com
Mahmoud Abdelrazik, MD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.